Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Medication Treatments

News
Initiative Targets Opioid Treatment, HIV Care in Hard-Hit Regions
03/02/2020
The New England and Appalachia regions have been immersed in addressing the opioid crisis for years, but by no means have found all the answers to maximizing crisis response. A multi-state initiative funded by the Health Resources and...
The New England and Appalachia regions have been immersed in addressing the opioid crisis for years, but by no means have found all the answers to maximizing crisis response. A multi-state initiative funded by the Health Resources and...
The New England and Appalachia...
03/02/2020
Addiction Professional
News
Painstaking Search for Existing Drugs to Treat Stimulant Addiction Continues
02/06/2020
The absence of an approved medication treatment for stimulant dependence has intensified the effort to identify existing drugs or drug combinations that could help reduce craving and improve treatment engagement. But history reminds that hype...
The absence of an approved medication treatment for stimulant dependence has intensified the effort to identify existing drugs or drug combinations that could help reduce craving and improve treatment engagement. But history reminds that hype...
The absence of an approved...
02/06/2020
Addiction Professional
News
Research Highlights Risk-Benefit Analysis Around Buprenorphine with Benzodiazepines
01/13/2020
Retention in treatment poses a significant challenge for patients receiving buprenorphine for opioid use disorder (OUD), and a new study confirms that an approach that can improve treatment engagement for some patients also carries...
Retention in treatment poses a significant challenge for patients receiving buprenorphine for opioid use disorder (OUD), and a new study confirms that an approach that can improve treatment engagement for some patients also carries...
Retention in treatment poses a...
01/13/2020
Addiction Professional
News
Study Suggests Benefits of Buprenorphine Treatment Beyond One Year
12/17/2019
Shedding light on the ongoing discussion of the ideal duration of medication treatment for opioid use disorder (OUD), a new study has reported more favorable post-treatment outcomes for patients who had received buprenorphine for longer...
Shedding light on the ongoing discussion of the ideal duration of medication treatment for opioid use disorder (OUD), a new study has reported more favorable post-treatment outcomes for patients who had received buprenorphine for longer...
Shedding light on the ongoing...
12/17/2019
Addiction Professional
News
Services Under Medicaid Struggle to Keep Up with Demand
11/21/2019
More North Carolina Medicaid patients with an opioid use disorder (OUD) are receiving medication treatment, but growth in this number is still not keeping pace with the demand for services, suggests an analysis from researchers at Duke...
More North Carolina Medicaid patients with an opioid use disorder (OUD) are receiving medication treatment, but growth in this number is still not keeping pace with the demand for services, suggests an analysis from researchers at Duke...
More North Carolina Medicaid...
11/21/2019
Addiction Professional
News
NCAD West: Streamlined Medication Unit Brings Treatment to Rural Communities
10/24/2019
In sprawling states where residents could be hours away from the nearest traditional opioid treatment program, innovative solutions are needed to deliver treatment to those who need it. In a Friday morning session at the National Conference...
In sprawling states where residents could be hours away from the nearest traditional opioid treatment program, innovative solutions are needed to deliver treatment to those who need it. In a Friday morning session at the National Conference...
In sprawling states where...
10/24/2019
Addiction Professional
News
NCAD West: Prescription Opioid Misuse Drops, but Providers Need to Stay Vocal
10/24/2019
“We’re making progress,” Robert Valuck, PhD, RPh, FNAP, told attendees Thursday at the National Conference on Addiction Disorders West in Denver, “but we need to make more, and we need to make it faster.”
“We’re making progress,” Robert Valuck, PhD, RPh, FNAP, told attendees Thursday at the National Conference on Addiction Disorders West in Denver, “but we need to make more, and we need to make it faster.”
“We’re making progress,” Robert...
10/24/2019
Addiction Professional
News
NCAD West: Focus on Function When Treating Chronic Pain
10/24/2019
All pain is real, Mel Pohl, MD, DFASAM, told NCAD West attendees on Thursday afternoon in Denver. But, as he went on to explain during his session, the way acute pain and chronic pain affect patients’ bodies are different, and they need to be...
All pain is real, Mel Pohl, MD, DFASAM, told NCAD West attendees on Thursday afternoon in Denver. But, as he went on to explain during his session, the way acute pain and chronic pain affect patients’ bodies are different, and they need to be...
All pain is real, Mel Pohl, MD,...
10/24/2019
Addiction Professional
News
Company Working Toward Once-Yearly Naltrexone Product
10/24/2019
A life sciences company that has developed implant technology for sustained-release formulations of drugs has its sights set on a potentially groundbreaking improvement in adherence to medication treatment for opioid use disorder (OUD).
A life sciences company that has developed implant technology for sustained-release formulations of drugs has its sights set on a potentially groundbreaking improvement in adherence to medication treatment for opioid use disorder (OUD).
A life sciences company that has...
10/24/2019
Addiction Professional
News
Research Bolsters Hazelden Betty Ford`s Embrace of MAT
10/09/2019
Hazelden Betty Ford Foundation's decision nearly seven years ago to break from tradition among industry peers by implementing extended medication-assisted treatment (MAT) for opioid use disorder (OUD) within a 12-Step environment has received...
Hazelden Betty Ford Foundation's decision nearly seven years ago to break from tradition among industry peers by implementing extended medication-assisted treatment (MAT) for opioid use disorder (OUD) within a 12-Step environment has received...
Hazelden Betty Ford Foundation's...
10/09/2019
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement